Photo: Closeup of microscope

Rituximab

Rituximab (also known as Rituxan or Mabthera) is already licensed to treat some lymphomas, and is being tested as a treatment for MS.

Current phase of trial: phase 2

Type of MS: relapsing and progressive MS

Read more about rituximab